Related references
Note: Only part of the references are listed.Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
H. A. Wakelee et al.
ANNALS OF ONCOLOGY (2010)
Characterization of Melanoma Cells Capable of Propagating Tumors from a Single Cell
Matthew A. Held et al.
CANCER RESEARCH (2010)
Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition
Jianbo Yang et al.
CANCER RESEARCH (2009)
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2009)
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression
Koji Morimoto et al.
CANCER SCIENCE (2009)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
Current systemic therapy for metastatic melanoma
Sanjiv S. Agarwala
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Feng Jiang et al.
MOLECULAR CANCER RESEARCH (2009)
ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells
Julie Douville et al.
STEM CELLS AND DEVELOPMENT (2009)
Identification of cells initiating human melanomas
Tobias Schatton et al.
NATURE (2008)
Efficient tumour formation by single human melanoma cells
Elsa Quintana et al.
NATURE (2008)
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Scott J. Dylla et al.
PLOS ONE (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Melanoma biology and new targeted therapy
Vanessa Gray-Schopfer et al.
NATURE (2007)
Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells
Radley T. Estes et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Malignant melanoma: genetics and therapeutics in the genomic era
Lynda Chin et al.
GENES & DEVELOPMENT (2006)
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells
John P. Chute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A tumorigenic subpopulation with stem cell properties in melanomas
D Fang et al.
CANCER RESEARCH (2005)
Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples
DJ Pearce et al.
STEM CELLS (2005)
Human aldehyde dehydrogenases: Potential pathological, pharmacological, and toxicological impact
NE Sladek
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2003)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)